A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS ® in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg; Drug: ADVAIR DISKUS Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials